The scariest thing about gray-market peptides is how little we know
This is Optimizer, a weekly newsletter sent from Verge senior reviewer Victoria Song that dissects and discusses the latest gizmos and potions that swear they're going to change your life. Opt in for Optimizer here. Finding concrete data about gray-market peptides is a Sisyphean task. Unlike bona fide clinical drug trials, there are no official […]
We haven't written up this one. The Verge has the full story — the link below goes straight to it.
